Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

BACKGROUND: A growing body of evidence suggests that the plasma concentration of the neurofilament light chain (NfL) might be considered a plasma biomarker for the screening of neurodegeneration in Alzheimer’s disease (AD). METHODS: With a single molecule array method (Simoa, Quanterix), plasma NfL...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Alzheimers Res Ther
Hlavní autoři: Lewczuk, Piotr, Ermann, Natalia, Andreasson, Ulf, Schultheis, Christian, Podhorna, Jana, Spitzer, Philipp, Maler, Juan Manuel, Kornhuber, Johannes, Blennow, Kaj, Zetterberg, Henrik
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6064615/
https://ncbi.nlm.nih.gov/pubmed/30055655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0404-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky